FDAFDA · Food and drugs·Recall number D-0622-2024
Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.125mg, 60 tablets per carton (10 blister cards containing 6 tablets each), Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC# 49884-306-02.
Published August 7, 2024 · Recall initiated: July 10, 2024
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25 mg. The blister strips inside the product carton reflect the correct strength of 0.25 mg.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- CLONAZEPAM
- Manufacturer
- Endo Pharmaceuticals, Inc.
- Distributor
- Nationwide in the USA and Puerto Rico
- Lot
- Lot 550147301, Exp. 08/31/2026
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.